share_log

翰宇药业(300199.SZ):注射用特利加压素获得智利的上市许可

Hybio Pharmaceutical (300199.SZ): Injection Terlipressin has obtained market authorization in Chile.

Gelonghui Finance ·  Jul 4 04:28

On July 4th, Gelunhui reported that Hybio pharmaceutical (300199.SZ) announced that recently, Shenzhen Hybio pharmaceutical co., LTD. received the approval certificate for injection terlipressin issued by the national drug management agency of Chile (ANAMED). Indications of injection terlipressin: treatment of esophageal variceal bleeding.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment